Whitehawk Therapeutics (WHWK) Shareholder's Equity Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Whitehawk Therapeutics | 312.26 Mn | 189.22 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 53.42% |
| Dec 31, 2025 | 66.94% |
| Sep 30, 2025 | 57.43% |
| Jun 30, 2025 | 63.71% |
| Mar 31, 2025 | 81.87% |
| Dec 31, 2024 | 50.69% |
| Sep 30, 2024 | 10.55% |
| Jun 30, 2024 | 11.50% |
| Mar 31, 2024 | 12.23% |
| Dec 31, 2023 | 12.39% |
| Sep 30, 2023 | 12.18% |
| Jun 30, 2023 | 22.36% |
| Mar 31, 2023 | 67.38% |
| Dec 31, 2022 | 55.47% |
| Sep 30, 2022 | 48.50% |
| Jun 30, 2022 | 31.23% |
| Mar 31, 2022 | 30.20% |
| Dec 31, 2021 | 29.07% |
| Sep 30, 2021 | 273.84% |
| Jun 30, 2021 | -149.46% |
| Mar 31, 2021 | -147.40% |
| Dec 31, 2020 | 28.51% |
| Sep 30, 2020 | -159.35% |
| Jun 30, 2020 | -153.59% |
| Mar 31, 2020 | -138.40% |
| Dec 31, 2019 | -125.76% |
| Sep 30, 2019 | 211.42% |
| Jun 30, 2019 | 220.05% |
| Mar 31, 2019 | 230.23% |
| Dec 31, 2018 | 242.92% |
| Sep 30, 2018 | 257.38% |
| Jun 30, 2018 | 238.46% |
| Mar 31, 2018 | 156.65% |
| Dec 31, 2017 | 183.92% |
| Sep 30, 2017 | 207.44% |
| Jun 30, 2017 | 223.06% |
| Mar 31, 2017 | 240.09% |
| Dec 31, 2016 | -317.25% |
| Sep 30, 2016 | -28.46% |
| Jun 30, 2016 | -30.53% |
| Dec 31, 2015 | -338.63% |